China Geriatric Medicine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.

    The elderly population basically exhibits conditions such as high cholesterol levels, low immune levels and high blood sugar levels, which greatly promotes the prevalence of target diseases such as hypertension, coronary heart disease, stroke, diabetes, and neurological diseases.

    One of the key factors contributing to the rapid growth of the geriatric medicine market is the rapid increase in the elderly population. The global prevalence of various target diseases has risen, immunity has fallen, and the significant improvement of the healthcare system has greatly promoted the growth of the market.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Geriatric Medicine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Geriatric Medicine market. Detailed analysis of key players, along with key growth strategies adopted by Geriatric Medicine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GSK

    • AstraZeneca

    • Eli Lilly

    • Abbott

    • Novartis

    • Pfizer

    • Merck

    • Boehringer Ingelheim

    • Bristol-Myers Squibb

    By Type:

    • Analgesics

    • Antihypertensives

    • Antidiabetics

    • Antipsychotic

    • Antidepressant

    • Other

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Geriatric Medicine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Geriatric Medicine Market Size and Growth Rate of Analgesics from 2016 to 2027

    • 1.3.2 China Geriatric Medicine Market Size and Growth Rate of Antihypertensives from 2016 to 2027

    • 1.3.3 China Geriatric Medicine Market Size and Growth Rate of Antidiabetics from 2016 to 2027

    • 1.3.4 China Geriatric Medicine Market Size and Growth Rate of Antipsychotic from 2016 to 2027

    • 1.3.5 China Geriatric Medicine Market Size and Growth Rate of Antidepressant from 2016 to 2027

    • 1.3.6 China Geriatric Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Geriatric Medicine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Geriatric Medicine Market Size and Growth Rate of Clinics from 2016 to 2027

    • 1.4.3 China Geriatric Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Geriatric Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Geriatric Medicine by Major Types

    • 3.4.1 Market Size and Growth Rate of Analgesics

    • 3.4.2 Market Size and Growth Rate of Antihypertensives

    • 3.4.3 Market Size and Growth Rate of Antidiabetics

    • 3.4.4 Market Size and Growth Rate of Antipsychotic

    • 3.4.5 Market Size and Growth Rate of Antidepressant

    • 3.4.6 Market Size and Growth Rate of Other

    4 Segmentation of Geriatric Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Geriatric Medicine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Geriatric Medicine in Hospitals

    • 4.4.2 Market Size and Growth Rate of Geriatric Medicine in Clinics

    • 4.4.3 Market Size and Growth Rate of Geriatric Medicine in Other

    5 Market Analysis by Regions

    • 5.1 China Geriatric Medicine Production Analysis by Regions

    • 5.2 China Geriatric Medicine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Geriatric Medicine Landscape Analysis

    • 6.1 North China Geriatric Medicine Landscape Analysis by Major Types

    • 6.2 North China Geriatric Medicine Landscape Analysis by Major End-Users

    7 Central China Geriatric Medicine Landscape Analysis

    • 7.1 Central China Geriatric Medicine Landscape Analysis by Major Types

    • 7.2 Central China Geriatric Medicine Landscape Analysis by Major End-Users

    8 South China Geriatric Medicine Landscape Analysis

    • 8.1 South China Geriatric Medicine Landscape Analysis by Major Types

    • 8.2 South China Geriatric Medicine Landscape Analysis by Major End-Users

    9 East China Geriatric Medicine Landscape Analysis

    • 9.1 East China Geriatric Medicine Landscape Analysis by Major Types

    • 9.2 East China Geriatric Medicine Landscape Analysis by Major End-Users

    10 Northeast China Geriatric Medicine Landscape Analysis

    • 10.1 Northeast China Geriatric Medicine Landscape Analysis by Major Types

    • 10.2 Northeast China Geriatric Medicine Landscape Analysis by Major End-Users

    11 Southwest China Geriatric Medicine Landscape Analysis

    • 11.1 Southwest China Geriatric Medicine Landscape Analysis by Major Types

    • 11.2 Southwest China Geriatric Medicine Landscape Analysis by Major End-Users

    12 Northwest China Geriatric Medicine Landscape Analysis

    • 12.1 Northwest China Geriatric Medicine Landscape Analysis by Major Types

    • 12.2 Northwest China Geriatric Medicine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 GSK

      • 13.1.1 GSK Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 AstraZeneca

      • 13.2.1 AstraZeneca Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Eli Lilly

      • 13.3.1 Eli Lilly Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Abbott

      • 13.4.1 Abbott Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Novartis

      • 13.5.1 Novartis Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Pfizer

      • 13.6.1 Pfizer Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Merck

      • 13.7.1 Merck Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Boehringer Ingelheim

      • 13.8.1 Boehringer Ingelheim Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Bristol-Myers Squibb

      • 13.9.1 Bristol-Myers Squibb Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Geriatric Medicine Market Size and Growth Rate of Analgesics from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Antihypertensives from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Antidiabetics from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Antipsychotic from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Antidepressant from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure China Geriatric Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Geriatric Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Geriatric Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Geriatric Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Geriatric Medicine by Different Types from 2016 to 2027

    • Table Consumption Share of Geriatric Medicine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Analgesics

    • Figure Market Size and Growth Rate of Antihypertensives

    • Figure Market Size and Growth Rate of Antidiabetics

    • Figure Market Size and Growth Rate of Antipsychotic

    • Figure Market Size and Growth Rate of Antidepressant

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Geriatric Medicine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Geriatric Medicine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Other

    • Table China Geriatric Medicine Production by Regions

    • Table China Geriatric Medicine Production Share by Regions

    • Figure China Geriatric Medicine Production Share by Regions in 2016

    • Figure China Geriatric Medicine Production Share by Regions in 2021

    • Figure China Geriatric Medicine Production Share by Regions in 2027

    • Table China Geriatric Medicine Consumption by Regions

    • Table China Geriatric Medicine Consumption Share by Regions

    • Figure China Geriatric Medicine Consumption Share by Regions in 2016

    • Figure China Geriatric Medicine Consumption Share by Regions in 2021

    • Figure China Geriatric Medicine Consumption Share by Regions in 2027

    • Table North China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table North China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure North China Geriatric Medicine Consumption Share by Types in 2016

    • Figure North China Geriatric Medicine Consumption Share by Types in 2021

    • Figure North China Geriatric Medicine Consumption Share by Types in 2027

    • Table North China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table North China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure North China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure North China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table Central China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table Central China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure Central China Geriatric Medicine Consumption Share by Types in 2016

    • Figure Central China Geriatric Medicine Consumption Share by Types in 2021

    • Figure Central China Geriatric Medicine Consumption Share by Types in 2027

    • Table Central China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table Central China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure Central China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure Central China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table South China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table South China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure South China Geriatric Medicine Consumption Share by Types in 2016

    • Figure South China Geriatric Medicine Consumption Share by Types in 2021

    • Figure South China Geriatric Medicine Consumption Share by Types in 2027

    • Table South China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table South China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure South China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure South China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table East China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table East China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure East China Geriatric Medicine Consumption Share by Types in 2016

    • Figure East China Geriatric Medicine Consumption Share by Types in 2021

    • Figure East China Geriatric Medicine Consumption Share by Types in 2027

    • Table East China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table East China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure East China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure East China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table Northeast China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table Northeast China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Geriatric Medicine Consumption Share by Types in 2016

    • Figure Northeast China Geriatric Medicine Consumption Share by Types in 2021

    • Figure Northeast China Geriatric Medicine Consumption Share by Types in 2027

    • Table Northeast China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure Northeast China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure Northeast China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table Southwest China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table Southwest China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Geriatric Medicine Consumption Share by Types in 2016

    • Figure Southwest China Geriatric Medicine Consumption Share by Types in 2021

    • Figure Southwest China Geriatric Medicine Consumption Share by Types in 2027

    • Table Southwest China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure Southwest China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure Southwest China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table Northwest China Geriatric Medicine Consumption by Types from 2016 to 2027

    • Table Northwest China Geriatric Medicine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Geriatric Medicine Consumption Share by Types in 2016

    • Figure Northwest China Geriatric Medicine Consumption Share by Types in 2021

    • Figure Northwest China Geriatric Medicine Consumption Share by Types in 2027

    • Table Northwest China Geriatric Medicine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Geriatric Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Geriatric Medicine Consumption Share by End-Users in 2016

    • Figure Northwest China Geriatric Medicine Consumption Share by End-Users in 2021

    • Figure Northwest China Geriatric Medicine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.